<unk>  is used in combination with the anti-cancer drug bortezomib and the corticoid dexamethasone for the treatment of multiple myeloma in adults who had received at least two previous treatments, including bortezomib and an immunomodulatory agent.
Panobinostat
Martinostat
Olaparib
Rucaparib
Teprotumumab
Vorinostat
Palbociclib
Dabrafenib